|
 |
 |
 |
| |
 |

 |
| Table 14. Reported cases of AIDS for male adults and adolescents by race/ethnicity and exposure category, 1998–2002—United States |
 |
 |
View PDF
|
|
 |
 |
 |
 |
 |
 |
 |
| |
Year of diagnosis |
Cumulative through 2002a |
| Exposure category |
1998 |
1999 |
2000 |
2001 |
2002 |
| |
White, not Hispanic |
| Male-to-male sexual contact |
9,210 |
8,271 |
7,378 |
7,093 |
7,143 |
237,610 |
| Injection drug use |
1,630 |
1,512 |
1,236 |
1,214 |
1,078 |
30,247 |
| Male-to-male sexual contact and injection drug use |
1,115 |
1,041 |
853 |
751 |
731 |
27,264 |
| Hemophilia/coagulation disorder |
101 |
107 |
73 |
81 |
59 |
3,926 |
| Heterosexual contact |
497 |
510 |
422 |
448 |
436 |
6,521 |
| Sex with injection drug user |
129 |
137 |
119 |
99 |
92 |
2,153 |
| Sex with person with hemophilia |
2 |
2 |
1 |
2 |
1 |
34 |
| Sex with HIV-infected transfusion recipient |
7 |
4 |
8 |
6 |
4 |
171 |
| Sex with HIV-infected person, risk not specified |
359 |
367 |
294 |
341 |
339 |
4,163 |
| Receipt of blood transfusion, blood components, or tissue |
62 |
56 |
54 |
46 |
44 |
3,232 |
| Other/risk not reported or identifiedb |
1,169 |
1,200 |
1,301 |
1,428 |
1,733 |
14,215 |
| Total |
13,784 |
12,697 |
11,317 |
11,061 |
11,224 |
323,015 |
| |
Black, not Hispanic |
| Male-to-male sexual contact |
4,873 |
4,757 |
4,245 |
4,442 |
4,536 |
88,130 |
| Injection drug use |
4,247 |
3,930 |
3,233 |
2,990 |
2,668 |
77,577 |
| Male-to-male sexual contact and injection drug use |
923 |
796 |
677 |
631 |
518 |
17,824 |
| Hemophilia/coagulation disorder |
25 |
22 |
10 |
13 |
13 |
590 |
| Heterosexual contact |
1,770 |
2,004 |
1,866 |
1,968 |
2,039 |
21,706 |
| Sex with injection drug user |
403 |
395 |
340 |
373 |
306 |
6,117 |
| Sex with person with hemophilia |
0 |
6 |
2 |
4 |
2 |
26 |
| Sex with HIV-infected transfusion recipient |
8 |
14 |
16 |
9 |
15 |
189 |
| Sex with HIV-infected person, risk not specified |
1,359 |
1,589 |
1,508 |
1,582 |
1,716 |
15,374 |
| Receipt of blood transfusion, blood components, or tissue |
54 |
45 |
65 |
39 |
72 |
1,177 |
| Other/risk not reported or identifiedb |
2,699 |
3,290 |
3,005 |
3,696 |
4,488 |
32,884 |
| Total |
14,591 |
14,844 |
13,101 |
13,779 |
14,334 |
239,888 |
| |
Hispanic |
| Male-to-male sexual contact |
2,902 |
2,747 |
2,402 |
2,451 |
2,567 |
53,547 |
| Injection drug use |
2,227 |
1,970 |
1,712 |
1,473 |
1,327 |
42,819 |
| Male-to-male sexual contact and injection drug use |
419 |
340 |
309 |
275 |
226 |
8,519 |
| Hemophilia/coagulation disorder |
22 |
10 |
10 |
3 |
3 |
441 |
| Heterosexual contact |
714 |
673 |
596 |
697 |
684 |
8,087 |
| Sex with injection drug user |
148 |
132 |
111 |
123 |
113 |
2,054 |
| Sex with person with hemophilia |
2 |
1 |
1 |
0 |
0 |
11 |
| Sex with HIV-infected transfusion recipient |
10 |
1 |
4 |
4 |
8 |
100 |
| Sex with HIV-infected person, risk not specified |
554 |
539 |
480 |
570 |
563 |
5,922 |
| Receipt of blood transfusion, blood components, or tissue |
19 |
25 |
24 |
17 |
27 |
622 |
| Other/risk not reported or identifiedb |
1,130 |
1,194 |
1,187 |
1,319 |
1,545 |
12,315 |
| Total |
7,433 |
6,959 |
6,240 |
6,235 |
6,379 |
126,350 |
| |
Asian/Pacific Islander |
| Male-to-male sexual contact |
194 |
177 |
163 |
206 |
212 |
3,998 |
| Injection drug use |
17 |
13 |
14 |
14 |
17 |
279 |
| Male-to-male sexual contact and injection drug use |
11 |
8 |
13 |
7 |
10 |
218 |
| Hemophilia/coagulation disorder |
3 |
2 |
3 |
1 |
3 |
74 |
| Heterosexual contact |
23 |
27 |
32 |
35 |
38 |
278 |
| Sex with injection drug user |
6 |
6 |
4 |
3 |
3 |
58 |
| Sex with person with hemophilia |
0 |
1 |
0 |
0 |
0 |
1 |
| Sex with HIV-infected transfusion recipient |
0 |
0 |
0 |
2 |
0 |
9 |
| Sex with HIV-infected person, risk not specified |
17 |
20 |
28 |
30 |
35 |
210 |
| Receipt of blood transfusion, blood components, or tissue |
7 |
4 |
1 |
4 |
4 |
117 |
| Other/risk not reported or identifiedb |
68 |
72 |
73 |
90 |
102 |
751 |
| Total |
323 |
303 |
299 |
357 |
386 |
5,715 |
| |
American Indian/Alaska Native |
| Male-to-male sexual contact |
57 |
66 |
77 |
58 |
73 |
1,207 |
| Injection drug use |
29 |
23 |
22 |
26 |
29 |
356 |
| Male-to-male sexual contact and injection drug use |
21 |
17 |
11 |
35 |
23 |
383 |
| Hemophilia/coagulation disorder |
2 |
1 |
0 |
0 |
1 |
31 |
| Heterosexual contact |
3 |
7 |
11 |
9 |
13 |
84 |
| Sex with injection drug user |
0 |
0 |
2 |
3 |
5 |
24 |
| Sex with person with hemophilia |
0 |
0 |
0 |
0 |
0 |
0 |
| Sex with HIV-infected transfusion recipient |
0 |
1 |
0 |
0 |
0 |
2 |
| Sex with HIV-infected person, risk not specified |
3 |
6 |
9 |
6 |
8 |
58 |
| Receipt of blood transfusion, blood components, or tissue |
0 |
1 |
1 |
0 |
0 |
8 |
| Other/risk not reported or identifiedb |
9 |
20 |
14 |
21 |
16 |
134 |
| Total |
121 |
135 |
136 |
149 |
155 |
2,203 |
| Total casesc |
36,305 |
34,957 |
31,131 |
31,611 |
32,513 |
697,718 |
|
|
|
 |
 |
| a |
Includes male adults and adolescents with a diagnosis AIDS, reported from the beginning of the epidemic through 2002. |
| b |
Includes hemophilia, blood transfusion, perinatal, and risk not reported or not identified. |
| c |
Includes male adults and adolescents of unknown race or multiple races. |
|
|
|
|
|
|
 |